Shanghai MicroPort Medical (Group) Co., Ltd. (MicroPort®) received the 2020 Global Performance Excellence Award (Best in Class) by Asia Pacific Quality Organization (APQO) on December 24, 2020. As the only Chinese company to receive this award in 2020, MicroPort® is delighted to win this international award for quality and make this the second consecutive award-winning year after getting the APQO Innovation Class Award in 2019.
The Global Performance Excellence Awards (GPEA), from APQO, is currently the only international award in science and technology management that recognizes the pursuit of Performance Excellence in organizations across countries and regions and is the only formal international accreditation on performance excellence. It adopts the Malcolm Baldrige Criteria for Performance Excellence, to be eligible; candidates are required to have been a winner of national quality awards granted by APQO member countries. This award is extremely valuable as it sets a benchmark of performance excellence for companies worldwide.
In recent years, MicroPort® has been given a number of prominent awards for quality, including Shanghai Municipality Quality Gold Prize 2018, Shanghai Municipality Quality Benchmarks and the National Quality Benchmarks both in 2019 and 2020. Winning the APQO Global Performance Excellence Award is further testimony to MicroPort®’s continuous dedication to excellence in quality management. Going forward, MicroPort® will continue to fulfill its vision of helping millions of people around the world to live a healthy life, by offering inclusive solutions to enhance and reshape lives through the development and distribution of quality service and medical products.
Established in 1985, the APQO is an autonomous, non-political and non-profit science and technology organization with the participation of quality institutions from 51 countries, which serves as a primary motivator for continuous improvement on goods and service quality, also acknowledging quality of life.